VEA
IMGO

Virtus ETF Advisers’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Virtus ETF Advisers’s Portfolio IMGO Stock Details IMGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,904
Closed -$140K – 508
2022
Q4 		$140K Sell
3,904
-4,285
-52% -$107K 0.07% 365
2022
Q3 		$123K Buy
8,189
+55
+0.7% +$892 0.05% 394
2022
Q2 		$109K Sell
8,134
-426
-5% -$6.76K 0.04% 412
2022
Q1 		$165K Sell
8,560
-505
-6% -$10.5K 0.07% 214
2021
Q4 		$215K Buy
+9,065
New +$210K 0.08% 197

Virtus ETF Advisers's IMGO Position: Q1 2023 in Review

Virtus ETF Advisers sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 3,904 shares — an estimated $140K sold.

Virtus ETF Advisers first reported a position in IMGO in Q4 2021 and held it in 5 quarters. The position peaked at $215K in Q4 2021. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

  • Virtus ETF Advisers reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
  • Virtus ETF Advisers sold 3,904 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $140K.
  • Virtus ETF Advisers first reported a position in Imago BioSciences, Inc. Common stock in Q4 2021 and held it in 5 quarters.
  • Virtus ETF Advisers's Imago BioSciences, Inc. Common stock position peaked at $215K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Virtus ETF Advisers's 13F filing for Q1 2023, filed 15 May 2023.